Enhanced Stem Cell Differentiation and Immunopurification of Genome Engineered Human Retinal Ganglion Cells
Autor: | Donald J. Zack, Jie Cheng, Xitiz Chamling, Derek S. Welsbie, Katherine L. Mitchell, Melissa M. Liu, Cynthia A. Berlinicke, Valentin M. Sluch |
---|---|
Rok vydání: | 2017 |
Předmět: |
Pluripotent Stem Cells
Retinal Ganglion Cells 0301 basic medicine Cellular differentiation Human Embryonic Stem Cells Stem cells Biology Stem cell marker Retinal ganglion Cell Line 03 medical and health sciences Translational Research Articles and Reviews medicine Humans Gene Delivery Systems / Gene Therapy / Gene Editing Technology Cellular Reprogramming Techniques Clustered regularly interspaced short palindromic repeats Induced pluripotent stem cell Embryonic Stem Cells Cells Cultured Gene Editing Developmental Biology / Embryo Development Cell Differentiation Cell Biology General Medicine MAP Kinase Kinase Kinases Embryonic stem cell Molecular biology Transcription Factor Brn-3B Neural/Progenitor Stem Cells 3. Good health Cell biology 030104 developmental biology medicine.anatomical_structure Retinal ganglion cell Disease Models (Animal/Cell) Cell culture Vision Loss / Repair sense organs CRISPR-Cas Systems Stem cell Biotechnology Developmental Biology |
Zdroj: | Stem Cells Translational Medicine |
ISSN: | 2157-6580 2157-6564 |
Popis: | Human pluripotent stem cells have the potential to promote biological studies and accelerate drug discovery efforts by making possible direct experimentation on a variety of human cell types of interest. However, stem cell cultures are generally heterogeneous and efficient differentiation and purification protocols are often lacking. Here, we describe the generation of clustered regularly-interspaced short palindromic repeats(CRISPR)-Cas9 engineered reporter knock-in embryonic stem cell lines in which tdTomato and a unique cell-surface protein, THY1.2, are expressed under the control of the retinal ganglion cell (RGC)-enriched gene BRN3B. Using these reporter cell lines, we greatly improved adherent stem cell differentiation to the RGC lineage by optimizing a novel combination of small molecules and established an anti-THY1.2-based protocol that allows for large-scale RGC immunopurification. RNA-sequencing confirmed the similarity of the stem cell-derived RGCs to their endogenous human counterparts. Additionally, we developed an in vitro axonal injury model suitable for studying signaling pathways and mechanisms of human RGC cell death and for high-throughput screening for neuroprotective compounds. Using this system in combination with RNAi-based knockdown, we show that knockdown of dual leucine kinase (DLK) promotes survival of human RGCs, expanding to the human system prior reports that DLK inhibition is neuroprotective for murine RGCs. These improvements will facilitate the development and use of large-scale experimental paradigms that require numbers of pure RGCs that were not previously obtainable. |
Databáze: | OpenAIRE |
Externí odkaz: |